カテゴリー： 世界, 医療/バイオ, 360iResearch

組換えタンパク質のグローバル市場（～2030）：接着分子・受容体、成長因子・ケモカイン、免疫応答タンパク質

【英語タイトル】Recombinant Proteins Market by Product (Adhesion Molecules & Receptors, Growth Factors & Chemokines, Immune Response Proteins), Services (Cloning, Expression, Purification), End-User, Function - Global Forecast 2023-2030

360iResearchが出版した調査資料（360i23N019）・商品コード：360i23N019
・発行会社（調査会社）：360iResearch
・発行日：2023年10月
・ページ数：186
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（2～3営業日）
・調査対象地域：グローバル
・産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名利用、印刷可）USD4,949 ⇒換算￥732,452見積依頼/購入/質問フォーム
Enterprise License（企業利用、印刷可）USD8,949 ⇒換算￥1,324,452見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

組換えタンパク質市場規模は、2022年の43.6億米ドルから2030年には130.4億米ドルに達すると予測され、予測期間中の年平均成長率は14.67%です。
市場細分化とカバー範囲：
この調査レポートは、組換えタンパク質市場の包括的な見通しを提供するために、様々なサブ市場を分析し、収益を予測し、各カテゴリの新たな動向を調査しています。
● 製品別では、接着分子＆受容体、成長因子＆ケモカイン、免疫応答タンパク質、キナーゼタンパク質、膜タンパク質、組換え代謝酵素、調節タンパク質、構造タンパク質について調査しています。2022年の市場シェアは、成長因子とケモカインが23.76%で最大、次いで膜タンパク質でした。
● サービス別では、クローニング、発現、精製が調査対象です。2022年の市場シェアは、発現が39.54%で最大、次いで精製でした。
● エンドユーザー別では、市場は学術研究機関、受託研究機関および受託製造機関、製薬・バイオ製薬会社で調査されます。2022年の市場シェアは製薬・バイオ製薬企業が54.54%と最も高く、次いで受託研究機関・受託製造機関でした。
● 機能別では、診断薬市場と創薬・医薬品開発市場を調査しています。創薬・医薬品開発はさらに生物製剤、細胞・遺伝子治療、ワクチンで調査しています。2022年の市場シェアは、創薬・医薬品開発が67.54%と最も高く、次いで診断薬でした。
● 地域別では、南北アメリカ、アジア太平洋、ヨーロッパ、中東、アフリカで調査を行いました。詳しい内訳は、南北アメリカはアルゼンチン、ブラジル、カナダ、メキシコ、アメリカを対象に、アメリカはさらにカリフォルニア、フロリダ、イリノイ、ニューヨーク、オハイオ、ペンシルバニア、テキサスを対象に調査を行いました。アジア太平洋地域は、オーストラリア、中国、インド、インドネシア、日本、マレーシア、フィリピン、シンガポール、韓国、台湾、タイ、ベトナムでした。ヨーロッパ・中東・アフリカは、デンマーク、エジプト、フィンランド、フランス、ドイツ、イスラエル、イタリア、オランダ、ナイジェリア、ノルウェー、ポーランド、カタール、ロシア、サウジアラビア、南アフリカ、スペイン、スウェーデン、スイス、トルコ、アラブ首長国連邦、イギリスを対象としています。2022年の市場シェアは、南北アメリカが41.52%で最大、その後をヨーロッパ・中東・アフリカが続きました。

市場統計：
本レポートでは、主要7通貨（米ドル、ユーロ、日本円、英ポンド、豪ドル、カナダドル、スイスフラン）の市場規模と予測を提供しています。本レポートでは、2018年から2021年を過去年、2022年を基準年、2023年を推定年、2024年から2030年を予測期間としています。

FPNVポジショニングマトリックス：
FPNVポジショニングマトリックスは、組換えタンパク質市場を評価するための不可欠なツールです。事業戦略と製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります： フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析：
市場シェア分析では、組換えタンパク質市場のベンダーランドスケープに関する貴重な洞察を提供します。全体的な収益、顧客基盤、その他の主要指標に対する影響を評価することで、各社の業績と直面している競争環境について包括的な理解を提供します。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競争レベルも明らかにします。

主要企業のプロフィール：
本レポートでは、組換えタンパク質市場における最近の重要な動向を掘り下げ、主要ベンダーとその革新的なプロフィールを紹介しています。これには、Abcam PLC, Abnova Corporation, Agilent Technologies, Inc., Bhat Bio-tech India Private Limited, Bio-Rad Laboratories, Inc., Biogen Inc., BioLegend, Inc. by PerkinElmer, Inc., Biologics International Corp, BPS Bioscience, Inc., Bristol-Myers Squibb Company, Creative BioMart Inc., Croyez Bioscience Co., Ltd., Eli Lilly and Company, Enzo Life Sciences, Inc., Fortis Life Sciences LLC, GenScript Biotech Corporation, GeoVax Labs, Inc., Hzymes Biotech, Johnson & Johnson Services, Inc., Laurus Labs Limited, LenioBio GmbH, Lonza Group AG, Marin Biologic Laboratories, Inc., Merck KGaA, Meridian Bioscience, Inc. by SD Biosensor Inc., Miltenyi Biotec B.V. & Co. KG, Novartis AG, ProMab Biotechnologies, Inc., Proteintech Group, Inc., Proteos, Inc., R&D Systems, Inc. by Bio-Techne Corporation, Sanofi S.A., Sartorius AG, Selvita S.A., Sino Biological, Inc., SK bioscience, Takara Bio Inc., Takeda Pharmaceutical Company Limited, and Thermo Fisher Scientific, Inc.などが含まれます。

本レポートでは、以下の点について貴重な洞察を提供しています：
1. 市場浸透： 主要企業の市場ダイナミクスと製品に関する包括的な情報を提供します。
2. 市場開拓： 新興市場と成熟市場セグメントへの浸透を詳細に分析し、有利な機会を強調します。
3. 市場の多様化： 新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報を記載しています。
4. 競合他社の評価とインテリジェンス： 主要企業の市場シェア、戦略、製品、認証、規制当局の承認、特許状況、製造能力を網羅的に評価しています。
5. 製品開発とイノベーション： 将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を行いました。

本レポートは、以下のような主要な質問に対応しています：
1. 組換えタンパク質市場の市場規模および予測はどのようになっていますか？
2. 組換えタンパク質市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野はどこですか？
3. 組換えタンパク質市場の機会を特定するための競争戦略窓口はどのようになっていますか？
4. 組換えタンパク質市場における最新の技術動向と規制の枠組みはどのようになっていますか？
5. 組換えタンパク質市場における主要ベンダーの市場シェアはどのようになっていますか？
6. 組換えタンパク質市場への参入に適したモードと戦略的動きはどのようになっていますか？

1. 序論
2. 調査方法
3. エグゼクティブサマリー
4. 市場概要
5. 市場インサイト
6. 組換えタンパク質の市場分析：製品別
7. 組換えタンパク質の市場分析：サービス別
8. 組換えタンパク質の市場分析：エンドユーザー別
9. 組換えタンパク質の市場分析：機能別
10. 南北アメリカの組換えタンパク質市場
11. アジア太平洋の組換えタンパク質市場
12. ヨーロッパ・中東・アフリカの組換えタンパク質市場
13. 競争状況
14. 競争ポートフォリオ
15. 付録

❖ レポートの目次 ❖

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Recombinant Proteins Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising focus on personalized medicine & protein therapeutics in the consumers
5.1.1.2. High prevalence of infectious & chronic diseases among geriatric population and children
5.1.1.3. Surging inclination of demand toward biologics and biosimilars proteins
5.1.2. Restraints
5.1.2.1. Concerns regarding time consumption coupled with high costs & maintenance of recombinant protein
5.1.3. Opportunities
5.1.3.1. Increasing focus on biomarker discovery and surging investments recombinant protein development
5.1.3.2. Growing potential for recombinant protein in animal reproduction, feed efficiency, and health
5.1.4. Challenges
5.1.4.1. Availability of alternative products and several issues in production
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.3.1. Increase in research spending coupled with healthcare infrastructure across Americas
5.3.2. Prevalence of chronic diseases and significant investments in medical research in the APAC region
5.3.3. Expanding drug manufacturing facilities and regulatory guidelines for recombinant protein in the EMEA region.
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Recombinant Proteins Market, by Product
6.1. Introduction
6.2. Adhesion Molecules & Receptors
6.3. Growth Factors & Chemokines
6.4. Immune Response Proteins
6.5. Kinase Proteins
6.6. Membrane Proteins
6.7. Recombinant Metabolic Enzymes
6.8. Regulatory Proteins
6.9. Structural Proteins
7. Recombinant Proteins Market, by Services
7.1. Introduction
7.2. Cloning
7.3. Expression
7.4. Purification
8. Recombinant Proteins Market, by End-User
8.1. Introduction
8.2. Academic Research Institutes
8.3. Contract Research Organizations & Contract Manufacturing Organizations
8.4. Pharmaceutical & Biopharmaceutical Companies
9. Recombinant Proteins Market, by Function
9.1. Introduction
9.2. Diagnostics
9.3. Drug Discovery & Development
9.4.1. Biologics
9.4.2. Cell & Gene Therapy
9.4.3. Vaccines
10. Americas Recombinant Proteins Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Recombinant Proteins Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Recombinant Proteins Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Fortis Life Sciences acquires International Point of Care
13.3.1.2. Fujifilm to Acquire Shenandoah Biotechnology, Leading Manufacturer of Recombinant Proteins
13.3.1.3. Thermo Fisher Scientific Completes Acquisition of PeproTech, engaged in Recombinant Proteins
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. iTolerance and Northway Biotech Form Manufacturing Pact for Fusion Protein
13.3.2.2. Curia Expands Cell Line Development Offering with CHOZN Platform
13.3.3. New Product Launch & Enhancement
13.3.3.1. Shenandoah Biotechnology Introduces Expanded Range of CTGrade Recombinant Proteins Manufactured Following cGMP Practices
13.3.4. Investment & Funding
13.3.4.1. Biovian Invests Over EUR 50M in Manufacturing Facility in Finland
13.3.4.2. Future Fields raises USD 11.2 million to scale up fruit flies for recombinant protein production
13.3.5. Award, Recognition, & Expansion
13.3.5.1. Merck’s Biodevelopment Centre Expansion, Martillac, France
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Abcam PLC
14.1.2. Abnova Corporation
14.1.3. Agilent Technologies, Inc.
14.1.4. Bhat Bio-tech India Private Limited
14.1.5. Bio-Rad Laboratories, Inc.
14.1.6. Biogen Inc.
14.1.7. BioLegend, Inc. by PerkinElmer, Inc.
14.1.8. Biologics International Corp
14.1.9. BPS Bioscience, Inc.
14.1.10. Bristol-Myers Squibb Company
14.1.11. Creative BioMart Inc.
14.1.12. Croyez Bioscience Co., Ltd.
14.1.13. Eli Lilly and Company
14.1.14. Enzo Life Sciences, Inc.
14.1.15. Fortis Life Sciences LLC
14.1.16. GenScript Biotech Corporation
14.1.17. GeoVax Labs, Inc.
14.1.18. Hzymes Biotech
14.1.19. Johnson & Johnson Services, Inc.
14.1.20. Laurus Labs Limited
14.1.21. LenioBio GmbH
14.1.22. Lonza Group AG
14.1.23. Marin Biologic Laboratories, Inc.
14.1.24. Merck KGaA
14.1.25. Meridian Bioscience, Inc. by SD Biosensor Inc.
14.1.26. Miltenyi Biotec B.V. & Co. KG
14.1.27. Novartis AG
14.1.28. ProMab Biotechnologies, Inc.
14.1.29. Proteintech Group, Inc.
14.1.30. Proteos, Inc.
14.1.31. R&D Systems, Inc. by Bio-Techne Corporation
14.1.32. Sanofi S.A.
14.1.33. Sartorius AG
14.1.34. Selvita S.A.
14.1.35. Sino Biological, Inc.
14.1.36. SK bioscience
14.1.37. Takara Bio Inc.
14.1.38. Takeda Pharmaceutical Company Limited
14.1.39. Thermo Fisher Scientific, Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

TABLE 1. RECOMBINANT PROTEINS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018–2022
TABLE 3. RECOMBINANT PROTEINS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL RECOMBINANT PROTEINS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. RECOMBINANT PROTEINS MARKET SIZE, BY ADHESION MOLECULES & RECEPTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. RECOMBINANT PROTEINS MARKET SIZE, BY GROWTH FACTORS & CHEMOKINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. RECOMBINANT PROTEINS MARKET SIZE, BY IMMUNE RESPONSE PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. RECOMBINANT PROTEINS MARKET SIZE, BY KINASE PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. RECOMBINANT PROTEINS MARKET SIZE, BY MEMBRANE PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. RECOMBINANT PROTEINS MARKET SIZE, BY RECOMBINANT METABOLIC ENZYMES, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. RECOMBINANT PROTEINS MARKET SIZE, BY REGULATORY PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. RECOMBINANT PROTEINS MARKET SIZE, BY STRUCTURAL PROTEINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 15. RECOMBINANT PROTEINS MARKET SIZE, BY CLONING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. RECOMBINANT PROTEINS MARKET SIZE, BY EXPRESSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. RECOMBINANT PROTEINS MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 19. RECOMBINANT PROTEINS MARKET SIZE, BY ACADEMIC RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. RECOMBINANT PROTEINS MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS & CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. RECOMBINANT PROTEINS MARKET SIZE, BY PHARMACEUTICAL & BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 23. RECOMBINANT PROTEINS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 26. RECOMBINANT PROTEINS MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. RECOMBINANT PROTEINS MARKET SIZE, BY CELL & GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. RECOMBINANT PROTEINS MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 33. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 34. AMERICAS RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 39. ARGENTINA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 44. BRAZIL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 45. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 46. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 47. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 49. CANADA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 50. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 52. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 54. MEXICO RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES RECOMBINANT PROTEINS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 65. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 66. ASIA-PACIFIC RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 71. AUSTRALIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 72. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 73. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 74. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 76. CHINA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 77. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 78. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 79. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 81. INDIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 86. INDONESIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 87. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 88. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 89. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 91. JAPAN RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 96. MALAYSIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 101. PHILIPPINES RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 106. SINGAPORE RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 111. SOUTH KOREA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 116. TAIWAN RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 117. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 118. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 119. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 121. THAILAND RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 126. VIETNAM RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 133. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 134. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 135. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 137. DENMARK RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 138. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 139. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 140. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 142. EGYPT RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 143. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 144. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 145. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 147. FINLAND RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 148. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 150. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 152. FRANCE RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 153. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 154. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 155. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 157. GERMANY RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 162. ISRAEL RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 163. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 164. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 165. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 167. ITALY RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 172. NETHERLANDS RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NIGERIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 177. NIGERIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 178. NORWAY RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 179. NORWAY RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 180. NORWAY RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. NORWAY RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 182. NORWAY RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 183. POLAND RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 184. POLAND RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 185. POLAND RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. POLAND RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 187. POLAND RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 188. QATAR RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 189. QATAR RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 190. QATAR RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. QATAR RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 192. QATAR RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. RUSSIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 197. RUSSIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 202. SAUDI ARABIA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SOUTH AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 208. SPAIN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 209. SPAIN RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 210. SPAIN RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SPAIN RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 212. SPAIN RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SWEDEN RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 217. SWEDEN RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. SWITZERLAND RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 222. SWITZERLAND RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 223. TURKEY RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 224. TURKEY RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 225. TURKEY RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. TURKEY RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 227. TURKEY RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED ARAB EMIRATES RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 232. UNITED ARAB EMIRATES RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM RECOMBINANT PROTEINS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM RECOMBINANT PROTEINS MARKET SIZE, BY SERVICES, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM RECOMBINANT PROTEINS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. UNITED KINGDOM RECOMBINANT PROTEINS MARKET SIZE, BY FUNCTION, 2018-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM RECOMBINANT PROTEINS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, 2018-2030 (USD MILLION)
TABLE 238. RECOMBINANT PROTEINS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 239. RECOMBINANT PROTEINS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 240. RECOMBINANT PROTEINS MARKET LICENSE & PRICING


★調査レポート[組換えタンパク質のグローバル市場（～2030）：接着分子・受容体、成長因子・ケモカイン、免疫応答タンパク質] (コード：360i23N019)販売に関する免責事項を必ずご確認ください。
★調査レポート[組換えタンパク質のグローバル市場（～2030）：接着分子・受容体、成長因子・ケモカイン、免疫応答タンパク質]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 組換えタンパク質のグローバル市場（2023-2030）：接着分子＆受容体、成長因子＆ケモカイン、免疫応答タンパク質
  • 世界の組換えタンパク質市場（～2028年）：製品別（成長因子、ケモカイン、構造タンパク質、膜タンパク質）、用途別（創薬・開発（生物製剤、ワクチン、細胞・遺伝子治療）、研究、バイオ医薬品生産）、地域別
  • 世界の研究用タンパク質市場（2023-2030）：製品別（サイトカイン・成長因子、抗体）、宿主細胞別（哺乳類細胞、細菌細胞）、エンドユーザー別、地域別
  • 世界の組換えタンパク質市場（2023-2033)：製品・サービス別（サイトカイン・成長因子、抗体、酵素、その他）、用途別（生物製剤生産、創薬・開発、研究、診断、その他）、宿主細胞別（哺乳類系、細菌細胞、酵母・菌類、昆虫細胞、その他）、エンドユーザー別（バイオ医薬品・バイオテクノロジー企業、その他）、地域別
  • アクティブ創傷ケアのグローバル市場（2023～2028）：生体材料、代用皮膚、成長因子
  • 世界の軟骨修復/軟骨再生市場（～2028年）：治療手段別（細胞系（軟骨細胞移植、幹細胞、成長因子）、非細胞系（組織スキャフォールド））、用途別（硝子軟骨、線維軟骨）、部位別、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆